Research keywords (5)：
Immunology
, Allergy
, Inflammation and repair
, Tissue stem cells
, Respiratory medicine
Research theme for competitive and other funds (5)：
2020 - 2023 Molecular mechanisms on how alveolar epithelial cells respond to exogenous stress in COPD
2019 - 2023 Why is prognosis of lung transplant recipient from elderly donors poor? –Elucidation of mechanisms and establishment of therapeutic intervention strategy-
2018 - 2020 Apototic cell-induced supression of inflammation in the airway
2016 - 2018 Investigation of Axl receptor tyrosine kinase in COPD airways
2012 - 2014 Identification of microRNAs that regulate differentiation of human lung progenitor cells
Papers (87)：
Yoshinao Ono, Naoya Fujino, Takuya Saito, Shuichiro Matsumoto, Shuichi Konno, Takuto Endo, Manami Suzuki, Mitsuhiro Yamada, Yoshinori Okada, Hisatoshi Sugiura. Characterization of IL-6R-expressing monocytes in the lung of patients with chronic obstructive pulmonary disease. Respiratory investigation. 2024. 62. 5. 856-866
Mitsuhiro Yamada, Masato Takase, Kumi Nakaya, Tomohiro Nakamura, Mana Kogure, Naoki Nakaya, Naoya Fujino, Tsutomu Tamada, Chikashi Iwasaki, Manami Suzuki, et al. Fractional exhaled nitric oxide distribution and its relevant factors in the general adult population and its healthy subpopulation. The journal of allergy and clinical immunology. Global. 2024. 3. 3. 100253-100253
Takuya Saito, Naoya Fujino, Yorihiko Kyogoku, Mitsuhiro Yamada, Koji Okutomo, Yoshinao Ono, Shuichi Konno, Takuto Endo, Koji Itakura, Shuichiro Matsumoto, et al. Identification of Siglec-1-negative alveolar macrophages with proinflammatory phenotypes in chronic obstructive pulmonary disease. American journal of physiology. Lung cellular and molecular physiology. 2024. 326. 6. L672-L686
Nozomu Kimura, Yoko Tsukita, Risa Ebina-Shibuya, Eisaku Miyauchi, Mitsuhiro Yamada, Daisuke Narita, Ryota Saito, Chihiro Inoue, Naoya Fujino, Tomohiro Ichikawa, et al. Peripheral blood biomarkers associated with combination of immune checkpoint blockade plus chemotherapy in NSCLC. Cancer biomarkers : section A of Disease markers. 2024
